Lahey Clinic Inc. - PARENT ACCOUNT

Burlington, Massachusetts 01805

0 studies enrolling now · 5 studies all time

What they study most

Crohn Disease, Crohn's Disease, Metastatic Breast Cancer, Multiple Sclerosis, Relapsing-Remitting, UC (Urothelial Cancer)

Studies at this site

• A Study of CDPATH™ to Help Manage and Treat Crohn's Disease — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201) — Completed
• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration — Completed
• Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer — Completed
• A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease — Withdrawn before enrolling